Galectin-1 circumvents lysolecithin-induced demyelination through the modulation of microglial polarization/phagocytosis and oligodendroglial differentiation
Gal-1 treatment after LPC demyelination circumvented damage and enhanced remyelination.
•
Gal-1 shifted microglia from an M1 to an M2 phenotype.
•
Gal-1 increased myelin phagocytosis and improved oligodendroglial differentiation.
•
Gal-1 is a potential therapeutic tool against demyelinating diseases.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.